Effectiveness of medical supportive team for outpatients treated with sorafenib: a retrospective study

BACKGROUND: It is well known that molecular-targeted drugs, of which sorafenib (Nexavar®) is one, differ from previous anticancer drugs and cause various unusual adverse drug reactions. Treatment with sorafenib causes adverse drug reactions such as hand-foot skin reactions, hypertension, and diarrhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kajizono, Makoto, Aoyagi, Megumu, Kitamura, Yoshihisa, Sendo, Toshiaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677728/
https://www.ncbi.nlm.nih.gov/pubmed/26819717
http://dx.doi.org/10.1186/s40780-014-0005-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677728/
https://www.ncbi.nlm.nih.gov/pubmed/26819717
http://dx.doi.org/10.1186/s40780-014-0005-0

Ejemplares similares